Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 283

1.

CG island methylation changes near the GSTP1 gene in prostatic intraepithelial neoplasia.

Brooks JD, Weinstein M, Lin X, Sun Y, Pin SS, Bova GS, Epstein JI, Isaacs WB, Nelson WG.

Cancer Epidemiol Biomarkers Prev. 1998 Jun;7(6):531-6.

2.

Preneoplastic prostate lesions: an opportunity for prostate cancer prevention.

Nelson WG, De Marzo AM, Deweese TL, Lin X, Brooks JD, Putzi MJ, Nelson CP, Groopman JD, Kensler TW.

Ann N Y Acad Sci. 2001 Dec;952:135-44. Review.

PMID:
11795433
3.
4.

I105V polymorphism and promoter methylation of the GSTP1 gene in prostate adenocarcinoma.

Jerónimo C, Varzim G, Henrique R, Oliveira J, Bento MJ, Silva C, Lopes C, Sidransky D.

Cancer Epidemiol Biomarkers Prev. 2002 May;11(5):445-50.

5.

GSTP1 CpG island hypermethylation as a molecular biomarker for prostate cancer.

Nakayama M, Gonzalgo ML, Yegnasubramanian S, Lin X, De Marzo AM, Nelson WG.

J Cell Biochem. 2004 Feb 15;91(3):540-52. Review.

PMID:
14755684
6.

Reversal of GSTP1 CpG island hypermethylation and reactivation of pi-class glutathione S-transferase (GSTP1) expression in human prostate cancer cells by treatment with procainamide.

Lin X, Asgari K, Putzi MJ, Gage WR, Yu X, Cornblatt BS, Kumar A, Piantadosi S, DeWeese TL, De Marzo AM, Nelson WG.

Cancer Res. 2001 Dec 15;61(24):8611-6.

7.

Epigenetic heterogeneity of high-grade prostatic intraepithelial neoplasia: clues for clonal progression in prostate carcinogenesis.

Henrique R, Jerónimo C, Teixeira MR, Hoque MO, Carvalho AL, Pais I, Ribeiro FR, Oliveira J, Lopes C, Sidransky D.

Mol Cancer Res. 2006 Jan;4(1):1-8.

8.

Quantitation of GSTP1 methylation in non-neoplastic prostatic tissue and organ-confined prostate adenocarcinoma.

Jerónimo C, Usadel H, Henrique R, Oliveira J, Lopes C, Nelson WG, Sidransky D.

J Natl Cancer Inst. 2001 Nov 21;93(22):1747-52.

9.

Glutathione S-transferase pi (GSTP1) hypermethylation in prostate cancer: review 2007.

Meiers I, Shanks JH, Bostwick DG.

Pathology. 2007 Jun;39(3):299-304. Review.

PMID:
17558856
10.
11.

Detailed methylation analysis of the glutathione S-transferase pi (GSTP1) gene in prostate cancer.

Millar DS, Ow KK, Paul CL, Russell PJ, Molloy PL, Clark SJ.

Oncogene. 1999 Feb 11;18(6):1313-24.

12.

Preoperative serum DNA GSTP1 CpG island hypermethylation and the risk of early prostate-specific antigen recurrence following radical prostatectomy.

Bastian PJ, Palapattu GS, Lin X, Yegnasubramanian S, Mangold LA, Trock B, Eisenberger MA, Partin AW, Nelson WG.

Clin Cancer Res. 2005 Jun 1;11(11):4037-43.

14.

A quantitative promoter methylation profile of prostate cancer.

Jerónimo C, Henrique R, Hoque MO, Mambo E, Ribeiro FR, Varzim G, Oliveira J, Teixeira MR, Lopes C, Sidransky D.

Clin Cancer Res. 2004 Dec 15;10(24):8472-8.

15.

Prostate cancer detection by GSTP1 methylation analysis of postbiopsy urine specimens.

Gonzalgo ML, Pavlovich CP, Lee SM, Nelson WG.

Clin Cancer Res. 2003 Jul;9(7):2673-7.

16.

Epigenetic events, remodelling enzymes and their relationship to chromatin organization in prostatic intraepithelial neoplasia and prostatic adenocarcinoma.

Mohamed MA, Greif PA, Diamond J, Sharaf O, Maxwell P, Montironi R, Young RA, Hamilton PW.

BJU Int. 2007 Apr;99(4):908-15.

17.

Hypermethylation of the CpG islands in the promoter region of the GSTP1 gene in prostate cancer: a useful diagnostic and prognostic marker?

Bernardini S, Miano R, Iori R, Finazzi-Agrò E, Palmieri G, Ballerini S, Angeloni C, Orlandi A, Bellincampi L, Cortese C, Federici G.

Clin Chim Acta. 2004 Dec;350(1-2):181-8.

PMID:
15530476
18.

Quantitative GSTP1 methylation clearly distinguishes benign prostatic tissue and limited prostate adenocarcinoma.

Harden SV, Guo Z, Epstein JI, Sidransky D.

J Urol. 2003 Mar;169(3):1138-42.

PMID:
12576869
19.

Molecular detection of prostate cancer in urine by GSTP1 hypermethylation.

Cairns P, Esteller M, Herman JG, Schoenberg M, Jeronimo C, Sanchez-Cespedes M, Chow NH, Grasso M, Wu L, Westra WB, Sidransky D.

Clin Cancer Res. 2001 Sep;7(9):2727-30.

20.

MT1G hypermethylation is associated with higher tumor stage in prostate cancer.

Henrique R, Jerónimo C, Hoque MO, Nomoto S, Carvalho AL, Costa VL, Oliveira J, Teixeira MR, Lopes C, Sidransky D.

Cancer Epidemiol Biomarkers Prev. 2005 May;14(5):1274-8.

Items per page

Supplemental Content

Write to the Help Desk